These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28763804)

  • 1. Neurogenic Orofacial Weakness and Speech in Adults With Dysarthria.
    Solomon NP; Makashay MJ; Helou LB; Clark HM
    Am J Speech Lang Pathol; 2017 Aug; 26(3):951-960. PubMed ID: 28763804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple orofacial indices in amyotrophic lateral sclerosis.
    DePaul R; Brooks BR
    J Speech Hear Res; 1993 Dec; 36(6):1158-67. PubMed ID: 8114482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech-Language Pathologists' Use of Intelligibility Measures in Adults With Dysarthria.
    Gurevich N; Scamihorn SL
    Am J Speech Lang Pathol; 2017 Aug; 26(3):873-892. PubMed ID: 28772293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Bell M
    Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual and instrumental assessments of orofacial muscle tone in dysarthric and normal speakers.
    Dietsch AM; Solomon NP; Sharkey LA; Duffy JR; Strand EA; Clark HM
    J Rehabil Res Dev; 2014; 51(7):1127-42. PubMed ID: 25437151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syllabic timing in dysarthria.
    Ziegler W; Hartmann E; Hoole P
    J Speech Hear Res; 1993 Aug; 36(4):683-93. PubMed ID: 8377481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptual assessment of dysarthria: Comparison of a general and a detailed assessment protocol.
    Wannberg P; Schalling E; Hartelius L
    Logoped Phoniatr Vocol; 2016 Dec; 41(4):159-67. PubMed ID: 26443894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of weakness of orofacial muscles on swallowing and communication in FSHD.
    Mul K; Berggren KN; Sills MY; McCalley A; van Engelen BGM; Johnson NE; Statland JM
    Neurology; 2019 Feb; 92(9):e957-e963. PubMed ID: 30804066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orofacial Muscle Strength across the Dysarthrias.
    Clark HM; Duffy JR; Strand EA; Hanley H; Solomon NP
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polar-phase indices of perioral muscle reciprocity during syllable production in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2017 Dec; 19(6):616-627. PubMed ID: 28425760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility.
    Ray J
    Int J Orofacial Myology; 2002 Nov; 28():39-48. PubMed ID: 12572259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version.
    Icht M; Bergerzon-Bitton O; Ben-David BM
    Int J Lang Commun Disord; 2022 Sep; 57(5):1023-1049. PubMed ID: 35714104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling listener perception of speaker similarity in dysarthria.
    Lansford KL; Berisha V; Utianski RL
    J Acoust Soc Am; 2016 Jun; 139(6):EL209. PubMed ID: 27369174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internally Versus Externally Cued Speech in Parkinson's Disease and Cerebellar Disease.
    Weir-Mayta P; Spencer KA; Eadie TL; Yorkston K; Savaglio S; Woollcott C
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):583-595. PubMed ID: 28654941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.